LaChapelle Robin has filed 18 insider transactions across 1 company since September 2024.
Most recent transaction: a grant/award of 130000 shares of ArriVent BioPharma, Inc. ($AVBP) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 38,462,600 | 9999.99% | 0.34% |
| July 11, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2600 | $2.28 | 523,710.0000 | 35,006,114 | 0.50% | 0.01% |
| July 11, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 6503 | $2.28 | 530,213.0000 | 35,006,114 | 1.24% | 0.02% |
| July 11, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2050 | $0.00 | 410.0000 | 35,006,114 | 83.33% | 0.01% |
| July 11, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2600 | $0.00 | 12,873.0000 | 35,006,114 | 16.80% | 0.01% |
| July 11, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 6503 | $0.00 | 6,370.0000 | 35,006,114 | 50.52% | 0.02% |
| July 11, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2050 | $2.28 | 521,110.0000 | 35,006,114 | 0.39% | 0.01% |
| Feb. 3, 2025 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 31,469,328 | 9999.99% | 0.38% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2867 | $2.28 | 497,061.0000 | 33,502,347 | 0.58% | 0.01% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 7164 | $2.28 | 504,225.0000 | 33,502,347 | 1.44% | 0.02% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2471 | $2.28 | 506,696.0000 | 33,502,347 | 0.49% | 0.01% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 12364 | $3.65 | 519,060.0000 | 33,502,347 | 2.44% | 0.04% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2700 | $6.24 | 494,194.0000 | 33,502,347 | 0.55% | 0.01% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2867 | $0.00 | 22,637.0000 | 33,502,347 | 11.24% | 0.01% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 7164 | $0.00 | 15,473.0000 | 33,502,347 | 31.65% | 0.02% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 12364 | $0.00 | 18,865.0000 | 33,502,347 | 39.59% | 0.04% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2700 | $0.00 | 56,471.0000 | 33,502,347 | 4.56% | 0.01% |
| Sept. 19, 2024 | ArriVent BioPharma, Inc. | $AVBP | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2471 | $0.00 | 2,460.0000 | 33,502,347 | 50.11% | 0.01% |